Patients have been seeking an effective alternative to traditional eyelift surgery for many years. Working with fractional CO2 technology previously used for laser resurfacing treatments, a new fractional eyelift procedure, “The Madonna Lift” has been developed as a safe and effective alternative to traditional eyelid surgery. Since receiving FDA clearance in 2004, fractional laser resurfacing has benefited millions of patients. The Madonna Lift promises to increase that number.
Fractional CO2 works by using laser beam-like columns, targeting a very specific area while leaving surrounding tissue intact. These beams eradicate damaged fibers in the skin and encourage new tissue with fresh elasticity to grow back in its place. Because the whole of the skin is not affected, healing is quick and far less painful than other procedures.
The Madonna fractional eyelift dramatically reduces the appearance of dark circles and eye wrinkles, tightens upper and lower eyelid skin, and helps to elevate drooping eyebrows. It has a number of the benefits of a surgical eyelift without the risks and downtime. The only problem it is unable to address is bulging fat pads.
Metal eye shields are used during treatment to protect a patient’s eyes from injury. The only anesthesia needed for the procedure is a numbing cream that is applied to the eyelids; as a result, downtime is minimal.
A recent study of fractional eyelifts involving more than 100 participants showed dramatic and consistent results. In order to achieve the best results from the Madonna Lift, between three and five sessions, delivered at two to three week intervals are recommended.
Bruce E. Katz, M.D. is Clinical Professor of Dermatology at The Mount Sinai School of Medicine, Director of the Cosmetic Surgery & Laser Clinic at Mount Sinai Medial Center, and Director of the JUVA Skin & Laser Center located at 60 East 56th Street in Manhattan.